Based in Japan and India. Has led to 1 successful fundraise in Japan. Been working the space of Venture Capital and Private Equity for the last 3 years.

According to MHT, BioAnalytix LLC, a spin-off from the Barnett Institute of Chemical and Biological Analysis, raised seed funding of $858,000 from 11 investors, according to a federal filing.

The company analyzes and characterizes large-molecular biologic drugs and biosimilars Kirtland Poss, co-founder and CEO of BioAnalytix, said that the company was founded by itself and three others in recent months: Robert Garnick, consultant with Lone Mountain Biotechnology and Medical Devices Inc. In Las Vegas; Barry Karger, director of the Barnett Institute; and Billy Wu, senior analyst at Barnett and formerly Genentech.

Please note that this piece of work originally appeared in English at As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at

Leave a Reply

Your email address will not be published. Required fields are marked *